Allergies News and Research

Latest Allergies News and Research

FDA approval of long-acting injectable drug marks a vital expansion of HIV prevention options

Yesterday the U.S. Food and Drug Administration announced its first approval of a long-acting HIV prevention medication. Developed by ViiV Healthcare, the medicine is long-acting cabotegravir injected once every two months.

21 Dec 2021

Researchers study how brain deficits associated with HIV and cocaine addiction might add up

Researchers with the Del Monte Institute for Neuroscience at the University of Rochester are studying how the brain puts the 'brakes' on behavior. That may be different in individuals recovering from cocaine addiction and who are also HIV-positive.

21 Dec 2021

Measuring airway inflammation when diagnosing and treating asthma patients

In this interview, Carol Stonham, the head of a Locality Based FeNO referral service, talks to NewsMed about measuring airway inflammation when diagnosing and treating asthma patients.

From Bedfont® Scientific Ltd 21 Dec 2021

New method to detect SARS-CoV-2 helps get reliable results more quickly

You're worried that you may have been exposed to the coronavirus, so you decide to take a test. But which do you choose?

21 Dec 2021

Dreaded microbe can silence multiple types of pain, study suggests

Anthrax has a scary reputation. Widely known to cause serious lung infections in humans and unsightly, albeit painless, skin lesions in livestock and people, the anthrax bacterium has even been used as a weapon of terror.

20 Dec 2021

NIH scientists highlight the urgent need for universal coronavirus vaccines

A growing body of scientific evidence, considered together with ecological reality, strongly suggest that novel coronaviruses will continue to infect bats and other animal reservoirs and potentially emerge to pose a pandemic threat to humans.

16 Dec 2021

The Ronald Weiser Center for Prostate Cancer to be established with $30 million gift

University of Michigan Regent Ron Weiser has committed $30 million to Michigan Medicine to establish an innovative, patient-focused program in prostate cancer.

16 Dec 2021

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Clear, specific product labeling for sesame is crucial to prevent anaphylaxis

In 2021, the US Congress passed the Food Allergy Safety, Treatment, Education & Research Act which, among other things, added sesame to the list of allergens which are mandatory for inclusion on food labels by 2023.

15 Dec 2021

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

14 Dec 2021

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New research from the University of Virginia School of Medicine sheds light on why a fecal transplant can benefit patients with dangerous recurrent C. difficile infections – and suggests a way to improve patient outcomes.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

9 Dec 2021

Partnership develops stool sample processing kit to help inform WHO's policy update on childhood TB diagnosis

42 Technology, FIND, the global alliance for diagnostics, and Rutgers University have worked together to develop an innovative stool sample processing kit that has played a central role in informing the World Health Organization’s recent policy update to improve the diagnosis of tuberculosis in children.

9 Dec 2021

Systemic sclerosis more common among Black children than previously thought

An immune disease that can damage vital organs – and is supposedly rare in young people – is more common than previously thought among Black children, a study suggests.

8 Dec 2021

Study identifies several proteins that protect against disease development

Inflammatory processes are associated with a large range of human diseases, including rheumatic diseases and allergies. Protein biomarkers are measurable molecules that can have a prognostic value in patients, be used to diagnose disease, or indicate severity of disease.

8 Dec 2021

Guidelines may lead to over-diagnoses of milk allergy in infants

In an analysis of data on 1,303 healthy infants who were exclusively breastfed until at least 3 months of age, 38% and 74% of infants had multiple mild-to-moderate milk allergy symptoms- as defined by current allergy guidelines- at 3 months and 12 months old, respectively.

8 Dec 2021

International guidelines may lead to over-diagnosis of cow's milk allergy in children

International guidelines developed to help doctors diagnose cow's milk allergy may lead to over-diagnosis, according to University of Bristol-led research published in the journal Clinical and Experimental Allergy today [8 December].

7 Dec 2021

'Combination' adjuvant may boost the protective power of vaccines

Scientists at La Jolla Institute for Immunology and Massachusetts Institute of Technology, have found a possible way to improve the effectiveness of COVID-19 vaccines-;and any vaccine.

4 Dec 2021

Allergies News and Research

Latest Allergies News and Research

FDA approval of long-acting injectable drug marks a vital expansion of HIV prevention options

Researchers study how brain deficits associated with HIV and cocaine addiction might add up

Measuring airway inflammation when diagnosing and treating asthma patients

New method to detect SARS-CoV-2 helps get reliable results more quickly

Dreaded microbe can silence multiple types of pain, study suggests

NIH scientists highlight the urgent need for universal coronavirus vaccines

The Ronald Weiser Center for Prostate Cancer to be established with $30 million gift

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Clear, specific product labeling for sesame is crucial to prevent anaphylaxis

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

New insights about COVID-19 vaccination rates among people living with HIV

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

Partnership develops stool sample processing kit to help inform WHO's policy update on childhood TB diagnosis

Systemic sclerosis more common among Black children than previously thought

Study identifies several proteins that protect against disease development

Guidelines may lead to over-diagnoses of milk allergy in infants

International guidelines may lead to over-diagnosis of cow's milk allergy in children

'Combination' adjuvant may boost the protective power of vaccines

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in